ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is characterized by the absence of ER, PR, and HER2 expression and is considered the most aggressive and malignant subtype of breast cancer 3, accounting for approximately 15%-25% of all invasive breast cancers 4.